Frontier Medicines

About:

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Website: https://frontiermeds.com/

Twitter/X: frontiermeds

Top Investors: Deerfield, RA Capital Management, Deerfield Management, Deep Track Capital, Galapagos

Description:

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins that make them accessible to small-molecule drug discovery and development.

Total Funding Amount:

$256M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2018-01-01

Contact Email:

contact(AT)frontiermeds.com

Founders:

Chris Varma, Daniel Nomura

Number of Employees:

101-250

Last Funding Date:

2024-06-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai